Allergan OKs Shareholder Meeting In Win For Valeant, Ackman
Allergan Inc. lost more ground in its fight against a $53 billion takeover bid from Valeant Pharmaceuticals International Inc. and activist investor Bill Ackman, saying late Thursday it approved the suitors'...To view the full article, register now.
Already a subscriber? Click here to view full article